This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.
Is it Apt to Retain Alcon Stock in Your Portfolio for Now?
by Zacks Equity Research
ALC stays on investors' radar due to its Vision Care arm's performance and contributions from new products despite macro risks and stiff competition.
ALGN vs. SAUHY: Which Stock Is the Better Value Option?
by Zacks Equity Research
ALGN vs. SAUHY: Which Stock Is the Better Value Option?
Phibro Animal Health Stock Up 52.8% in a Year: What's Driving the Rise?
by Zacks Equity Research
PAHC stock is under investors' radar due to its booming animal health sales, new product lines and rising vaccine demand.
Zacks Investment Ideas feature highlights: Align Technology and Chipotle Mexican Grill
by Zacks Equity Research
ALGN and CMG trade well below highs, but rising earnings growth and strong long-term outlooks make them stocks to watch this July.
2 Top Stocks to Buy On the Dip Before July Rebounds
by Benjamin Rains
Exploring two strong, beaten-down stocks--Align Technology, Inc. (ALGN) and Chipotle Mexican Grill (CMG)--to consider buying on the dip in July.
Reasons to Add Align Technology Stock to Your Portfolio Now
by Zacks Equity Research
ALGN's Invisalign growth, iTero innovation and solid finances fuel optimism despite forex headwinds.
WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus
by Zacks Equity Research
West Pharmaceutical Services rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.
Is This the Right Time to Hold EYE Stock in Your Portfolio?
by Zacks Equity Research
National Vision gains from America's Best momentum and strategic revamp, but solvency issues and rising costs weigh on profitability.
TNDM Stock Gains on t:slim X2's Compatibility With FreeStyle Libre 3 +
by Zacks Equity Research
Tandem Diabetes' t:slim X2 pump with Control-IQ+ tech gains U.S. early access using FreeStyle Libre 3 Plus sensor.
Encompass Health Plans a 50-Bed Unit to Better Serve North Las Vegas
by Zacks Equity Research
EHC unveils plans for a 50-bed rehabilitation hospital in North Las Vegas, bringing improved health outcomes to the region's residents and further solidifying its Nevada footprint.
ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?
by Zacks Equity Research
Abbott gains Health Canada approval for its i-STAT TBI test, enabling rapid bedside concussion detection via whole blood.
Should You Add NVST Stock to Your Portfolio Right Now?
by Zacks Equity Research
Envista's global expansion, smart acquisitions, and strong balance sheet support growth but forex risks remain a drag.
Reasons to Add PAHC Stock to Your Portfolio Right Now
by Zacks Equity Research
Phibro's strong Animal Health momentum and global expansion bode well for investors.
Align Technology (ALGN) Up 3.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ALGN vs. MMSI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ALGN vs. MMSI: Which Stock Is the Better Value Option?
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ALGN Stock Might Rise Following the NMPA Approval in China
by Zacks Equity Research
Align Technology receives approval from the National Medical Products Administration in China for its Invisalign Palatal Expander System.
Here's How Much a $1000 Investment in Align Technology Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Zacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology
by Zacks Equity Research
Cardinal Health, Labcorp and Align Technology have been highlighted in this Industry Outlook article.
3 Dental Supplies Stocks Likely to Gain From US-China Trade Deal
by Indrajit Bandyopadhyay
Here we discuss three stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, LH and ALGN.
Align Technology (ALGN) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ALGN or SAUHY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ALGN vs. SAUHY: Which Stock Is the Better Value Option?
Does Align Technology (ALGN) Have the Potential to Rally 31.42% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 31.4% in Align Technology (ALGN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.